Daily News Podcast

Antibody cleared amyloid plaques, slowed cognitive decline

Publish date: July 27, 2018

 

An experimental agent slowed cognitive decline and cleared Alzheimer’s plaques. Can meteorology predict migraines? Why closing a patent foramen ovale is the right approach to prevent recurring ischemic stroke. And claims that cannabis relieves noncancer pain go up in smoke.

Listen to the MDedge Daily News for today’s top news.

Recommended Reading

MDedge Daily News: Fewer smokes mean fewer strokes
MDedge Endocrinology
MDedge Daily News: Do HPV vaccines really cut cancer risk?
MDedge Endocrinology
Parkinson’s disease patients have impaired insulin secretion
MDedge Endocrinology
Type 2 diabetes may promote Parkinson development
MDedge Endocrinology
Migraine and menopause: Longitudinal study shows what to expect
MDedge Endocrinology
Malpractice and pain management
MDedge Endocrinology
Diabetes, hypertension, smoking may raise risk for late-onset epilepsy
MDedge Endocrinology
Is fibromyalgia one disorder – or two?
MDedge Endocrinology
Is fish oil’s heart benefit a fish tale?
MDedge Endocrinology
Blood pressure meds cut cognitive impairment risk
MDedge Endocrinology